Evidence map›Paper›PMID 32222151›Full record

SynthesisWorld journal of surgical oncology2020

A pooled analysis of risk factors of surgically treated leiomyosarcoma of the colon in adults.

Yun Wang, Hao Wang, Zhi-Lu Yuan, Jing-Fei Zhao, Dian-Bo Dong, Qian Gao

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in World journal of surgical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Yun WangDepartment of Digestive System, Qinghai University Affiliated Hospital, Xining, 810000, Qinghai, China.
Hao WangDepartment of Intensive Care Medicine, Qinghai Province People's Hospital, Xining, 810007, China.
Zhi-Lu YuanDepartment of General Surgery, Liao Cheng The Third People's Hospital, Liaocheng, 252000, Shandong, People's Republic of China.
Jing-Fei ZhaoDepartment of General Surgery, Liao Cheng The Third People's Hospital, Liaocheng, 252000, Shandong, People's Republic of China.
Dian-Bo DongDepartment of Anorectal Medicine, Liao Cheng People's Hospital, Liaocheng, 252000, Shandong, People's Republic of China.
Qian GaoDepartment of Digestive System, Qinghai University Affiliated Hospital, Xining, 810000, Qinghai, China. qhgaoq@126.com.
Liaocheng People's Hospital · CNQinghai No.3 People's Hospital · CNQinghai University · CNQinghai University Affiliated Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis current systematic review aimed to evaluate the role of surgical management and risk factors by pooled cases from all identified patients with colonic leiomyosarcomas.

methodsThe authors searched the Ovid MEDLINE, Embase, PubMed, and Cochrane databases using the keywords "colonic," "colon," and "leiomyosarcoma." Risk factors of colonic leiomyosarcoma in the pooled cohort were also evaluated.

resultsBetween 1923 and 2019, 41 cases of colonic leiomyosarcoma were identified in 22 (53.7%) males and 19 (46.3%) females, with a mean and median age of 58.7 ± 2.2 years and 56.0 years. According to univariate analysis, smaller tumor size < 8 cm was significantly associated with longer progression-free survival (HR = 6.957, 95% CI 1.405-34.442; p = 0.017), and younger age < 60 years was trending toward better overall survival (HR = 2.765, 95% CI 0.924-8.272; p = 0.069).

conclusionsColonic leiomyosarcomas are rare neoplasms with aggressive clinical behaviors. Age < 60 years and tumor size < 8 cm were favorable factors for patients' better survival.

Indexed as

ColonColonic NeoplasmsHumansLeiomyosarcomaPrognosisProgression-Free SurvivalRisk FactorsSurvival RateTreatment OutcomeLeiomyosarcoma of the colonPrognostic factorsTreatment

Identifiers

PMID32222151
PMCPMC7103068
OpenAlexW3014061763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.